132 related articles for article (PubMed ID: 21960373)
1. [New developments in diagnosis and therapy of prostate cancer--from "active surveillance" to robotic-assisted surgery].
Krome S
Dtsch Med Wochenschr; 2011 Oct; 136 Suppl 3():S86-9. PubMed ID: 21960373
[No Abstract] [Full Text] [Related]
2. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer.
Carlucci JR; Nabizada-Pace F; Samadi DB
Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581
[TBL] [Abstract][Full Text] [Related]
3. [Active surveillance for screen-detected prostate cancer - a strategy for the future?].
Weissbach L; Schaefer C
Aktuelle Urol; 2010 Jul; 41(4):239-44. PubMed ID: 20661840
[TBL] [Abstract][Full Text] [Related]
4. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Rosser CJ; Parker A
J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
[No Abstract] [Full Text] [Related]
5. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
[TBL] [Abstract][Full Text] [Related]
6. Biochemical recurrence following robot-assisted radical prostatectomy: analysis of 1384 patients with a median 5-year follow-up.
Menon M; Bhandari M; Gupta N; Lane Z; Peabody JO; Rogers CG; Sammon J; Siddiqui SA; Diaz M
Eur Urol; 2010 Dec; 58(6):838-46. PubMed ID: 20869162
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the incidence and location of positive surgical margins in robotic assisted laparoscopic radical prostatectomy and open retropubic radical prostatectomy.
Smith JA; Chan RC; Chang SS; Herrell SD; Clark PE; Baumgartner R; Cookson MS
J Urol; 2007 Dec; 178(6):2385-9; discussion 2389-90. PubMed ID: 17936849
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for prostate cancer patients at high risk of recurrence following radical prostatectomy.
Andriole GL
Eur Urol; 1997; 32 Suppl 3():65-9. PubMed ID: 9267788
[TBL] [Abstract][Full Text] [Related]
10. Benign positive margins after radical prostatectomy means a poor prognosis--con.
Rubin MA; Montie JE
Urology; 2005 Feb; 65(2):221-3. PubMed ID: 15708026
[No Abstract] [Full Text] [Related]
11. [Adjuvant treatment of prostatic carcinoma after primary therapy. The "Early Prostate Cancer" Program].
Mansueto G; Longo F
Recenti Prog Med; 2002 Mar; 93(3):175-8. PubMed ID: 11942169
[No Abstract] [Full Text] [Related]
12. Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility?
van der Kwast TH
Eur Urol; 2006 Feb; 49(2):209-11. PubMed ID: 16417961
[No Abstract] [Full Text] [Related]
13. [Diagnosis and treatment of early-stage prostate carcinoma. Improved prognosis--fewer complications].
Bastian PJ; Stief CG
MMW Fortschr Med; 2010 May; 152(19):36. PubMed ID: 20556999
[No Abstract] [Full Text] [Related]
14. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
[TBL] [Abstract][Full Text] [Related]
15. States renewing attention to prostate cancer.
Rossiter C
NCSL Legisbrief; 2012 Sep; 20(36):1-2. PubMed ID: 23072022
[No Abstract] [Full Text] [Related]
16. [Do close but negative margins in radical prostatectomy specimens increase the risk of postoperative progression?].
Wirth M
Urologe A; 1998 Jul; 37(4):427-8. PubMed ID: 9738298
[No Abstract] [Full Text] [Related]
17. Elevated levels of peritumoral chondroitin sulfate are predictive of poor prognosis in patients treated by radical prostatectomy for early-stage prostate cancer.
Ricciardelli C; Quinn DI; Raymond WA; McCaul K; Sutherland PD; Stricker PD; Grygiel JJ; Sutherland RL; Marshall VR; Tilley WD; Horsfall DJ
Cancer Res; 1999 May; 59(10):2324-8. PubMed ID: 10344737
[TBL] [Abstract][Full Text] [Related]
18. Benign positive margins after radical prostatectomy means a poor prognosis--pro.
Djavan B; Milani S; Fong YK
Urology; 2005 Feb; 65(2):218-20. PubMed ID: 15708025
[No Abstract] [Full Text] [Related]
19. [Surgical therapy of locally confined prostate carcinoma].
Bendhack ML; Miller S; Ackermann R
Praxis (Bern 1994); 1997 Nov; 86(46):1819-24. PubMed ID: 9454283
[TBL] [Abstract][Full Text] [Related]
20. Why are a high overdiagnosis probability and a long lead time for prostate cancer screening so important?
Barry MJ; Mulley AJ
J Natl Cancer Inst; 2009 Mar; 101(6):362-3. PubMed ID: 19276451
[No Abstract] [Full Text] [Related]
[Next] [New Search]